ALEMBIC PHARMACEUTICALS
Back to Cashflow Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹444 Cr | ₹-438 Cr | ₹-262 Cr | ₹-217 Cr | ₹-597 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹444 Cr |
| Mar2024 | ₹-438 Cr |
| Mar2023 | ₹-262 Cr |
| Mar2022 | ₹-217 Cr |
| Mar2021 | ₹-597 Cr |
How is Cash Flow from Financing Activities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹444 Cr | Positive | |
| Mar2024 | ₹-438 Cr | Negative | |
| Mar2023 | ₹-262 Cr | Negative | |
| Mar2022 | ₹-217 Cr | Negative | |
| Mar2021 | ₹-597 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹13,902.6 Cr | -3% | -10.6% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -3% |
-10.6% |
-10% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses